Exclusive

Publication

Byline

Location

Little recourse for people who are harmed by covid vaccines

New Delhi, Jan. 15 -- With the government not taking responsibility and a compensation law non-existent, anyone suffering a major side-effect after receiving the coronavirus vaccine may be left with n... Read More


No indemnity clause in jab purchase pacts

NEW DELHI, Jan. 15 -- The government is yet to decide on providing indemnity to Serum Institute of India (SII) and Bharat Biotech International, and the purchase pacts with the two vaccine makers do n... Read More


Govt's 4-week gap for Serum jab may lead to lower efficacy

New Delhi, Jan. 14 -- The government's decision to administer the second dose of Covishield vaccine just four weeks after the first may lead to efficacy of just 53%, the vaccine's package insert showe... Read More


Bharat Biotech ships vaccines to 11 cities, more to be dispatched Thursday

NEW DELHI, Jan. 13 -- Bharat Biotech International shipped batches of Covaxin, its two-dose covid-19 vaccine, to 11 cities in India on Wednesday, a day after its Pune-based rival Serum Institute of In... Read More


No indemnity for vaccine makers in purchase pacts

New Delhi, Jan. 13 -- The government is yet to decide on providing indemnity to Serum Institute of India (SII) and Bharat Biotech International, and the purchase pacts with the two vaccine makers do n... Read More


Govt orders 11 mn doses

New Delhi, Jan. 12 -- The government on Monday signed a deal with Serum Institute of India to procure 11 million shots of its coronavirus vaccine, Covishield, at Rs.200 per dose, two people familiar w... Read More


Activists write to PM Modi on unethical practices at Covaxin's Bhopal trial site

New Delhi, Jan. 11 -- Activists involved with the Bhopal gas tragedy have written to Prime Minister Narendra Modi and health minister Harsh Vardhan about the unethical practices at the clinical trial ... Read More


Bharat Biotech says trial participant in Bhopal dies of poisoning

New Delhi, Jan. 9 -- A participant in Bharat Biotech International's Covaxin clinical trial in Bhopal died after getting either a shot of the covid-19 vaccine or placebo, and the cause of his death wa... Read More


Bharat Biotech, Serum Institute end public spat over vaccine

NEW DELHI, Jan. 8 -- The brief but public vaccine war that broke out between Serum Institute's Adar Poonawalla and Bharat Biotech's Krishna Ella ended on Tuesday, 5 January, ushering in a detente, wit... Read More


Bharat Bio, Serum end public spat

New Delhi, Jan. 6 -- The brief but public vaccine war that broke out between Serum Institute's Adar Poonawalla and Bharat Biotech's Krishna Ella ended on Tuesday, ushering in a detente, with the two s... Read More